Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions emphasize the promising nature of the research, with statements like 'Neoadjuvant MBTA immunotherapy prevents cancer recurrence' and remarks about how the results could revolutionize cancer surgery, reflecting enthusiasm. The mention of a former student author, Ondřej Uher, adds a personal and credible touch, while phrases like 'the future of cancer surgery is here' convey excitement about the study's potential impact.
Most discussions express strong support for the findings and implications, highlighting the significance of the research and its potential to change cancer treatment strategies.
The posts demonstrate high interest, especially with references to the innovative approach and the involvement of a notable author who is a former student, generating curiosity about future applications.
Many posts delve into specific details, such as the method's ability to prevent metastasis and the relevance of omitting certain therapy components, indicating deep engagement.
While the findings are viewed as promising, the overall perceived impact is moderate, mainly because these are preclinical results in mouse models, though they suggest significant potential.
Inject Before You Cut: The Future of Cancer Surgery Is Here Supporting Evidence: Uher O et al., Cancer Lett. 2025;612:217464. Neoadjuvant intratumoral MBT(A) immunotherapy prevented metastasis and recurrence in mouse models. doi:10.1016/j.canlet.2025.217464. https://t.co/jJmTYmtZsn
Neoadjuvant MBTA immunotherapy prevents cancer recurrence and metastases. One of the authors of the article is our former student Ondřej Uher. Read more: https://t.co/pYLUkY9Zvo https://t.co/Lhoc6ck9Uh
Neoadjuvantní MBTA imunoterapie zabraňuje recidivě rakoviny a metastázám. Jedním z autorů článku je náš bývalý student Ondřej Uher. Více zde: https://t.co/f2j7bkQ7xw https://t.co/FijTAlVIC6
Neoadjuvant MBTA immunotherapy prevents cancer recurrence and metastases. One of the authors of the article is our former student Ondřej Uher. Read more: pubmed.ncbi.nlm.nih.gov/39809356/
Inject Before You Cut The future of cancer surgery involves intratumoral immunotherapy administered prior to surgery, as a 2024 study shows. Tested in four mouse models, this approach reduces metastases, recurrence, and…
Join Dr Goodyears Newsletter httpsprescribedcomsubscribe. This episode features Dr Nathan Goodyear and Dr Jason R Williams discussing how combining Pulsed Electric Field therapy with systemic and surgical treatments is…
Neoadjuvant MBTA immunotherapy prevents cancer recurrence and metastases. One of the authors of the article is our former student Ondřej Uher. Read more: pubmed.ncbi.nlm.nih.gov/39809356/
Neoadjuvant MBTA immunotherapy prevents cancer recurrence and metastases. One of the authors of the article is our former student Ondřej Uher. Read more: https://t.co/pYLUkY9Zvo https://t.co/Lhoc6ck9Uh
Neoadjuvantní MBTA imunoterapie zabraňuje recidivě rakoviny a metastázám. Jedním z autorů článku je náš bývalý student Ondřej Uher. Více zde: pubmed.ncbi.nlm.nih.gov/39809356/
Neoadjuvantní MBTA imunoterapie zabraňuje recidivě rakoviny a metastázám. Jedním z autorů článku je náš bývalý student Ondřej Uher. Více zde: https://t.co/f2j7bkQ7xw https://t.co/FijTAlVIC6
Inject Before You Cut: The Future of Cancer Surgery Is Here Supporting Evidence: Uher O et al., Cancer Lett. 2025;612:217464. Neoadjuvant intratumoral MBT(A) immunotherapy prevented metastasis and recurrence in mouse models. doi:10.1016/j.canlet.2025.217464. https://t.co/jJmTYmtZsn